Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Verastem, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- −17 vs. Q3 2022
- Shares held
- 104.4M
- −22.9M (−18.0%) vs. Q3 2022
- Total value
- $42.0M
- −$66.2M (−61.2%) vs. Q3 2022
- New holders
- 9
- 18 more added
- Sold out
- 26
- 37 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VSTM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $363.5M |
| Q1 2026 | 155 | $431.5M |
| Q4 2025 | 143 | $590.6M |
| Q3 2025 | 118 | $526.5M |
| Q2 2025 | 111 | $218.3M |
| Q1 2025 | 100 | $261.0M |
| Q4 2024 | 92 | $175.9M |
| Q3 2024 | 77 | $79.5M |
| Q2 2024 | 68 | $43.5M |
| Q1 2024 | 70 | $199.0M |
| Q4 2023 | 58 | $135.8M |
| Q3 2023 | 57 | $136.2M |
| Q2 2023 | 61 | $119.9M |
| Q1 2023 | 80 | $40.5M |
| Q4 2022 | 89 | $42.0M |
| Q3 2022 | 109 | $108.2M |
| Q2 2022 | 123 | $127.2M |
| Q1 2022 | 140 | $162.7M |
| Q4 2021 | 153 | $241.8M |
| Q3 2021 | 147 | $354.8M |
| Q2 2021 | 152 | $468.7M |
| Q1 2021 | 135 | $246.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Verastem, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Creek Financial Management, LLC | 0 | $0 | 0.00% | −81,122−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −64,624−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −61,485−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −43,152−100.0% | Sold out |
| Middleton & Co Inc | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −27,950−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −29,221−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −15,797−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −15,010−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −14,169−100.0% | Sold out |
| Financial Advisors, LLC | 0 | $0 | 0.00% | −29,900−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −2,538−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −1,759−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −319−100.0% | Sold out |
| Beaumont Financial Partners, LLC | – | – | – | – | Not filed |
| Eaton Vance Management | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |